Sustained improvement in general health-related quality of life and work productivity in patients with moderate to severe psoriasis treated with guselkumab: 5-year data from clinical trial VOYAGE 2

被引：0

作者：

Reich, Kristian ^{[1
]}

Gordon, Kenneth B. ^{[2
]}

Foley, Peter ^{[3
]}

Lomaga, Mark ^{[4
]}

Han, Chenglong ^{[5
]}

Miller, Megan ^{[6
]}

You, Yin ^{[6
]}

Radtke, Marc Alexander ^{[7
]}

Wu, Jashin J. ^{[8
]}

Armstrong, April W. ^{[9
]}

机构：

[1] Univ Med Ctr Hamburg Eppendorf, Inst Hlth Serv Res Dermatol & Nursing, Translat Res Inflammatory Skin Dis, Hamburg, Germany

[2] Med Coll Wisconsin, Milwaukee, WI 53226 USA

[3] Univ Melbourne, St Vincents Hosp Melbourne & Prob Med Res, Skin Hlth Inst, Melbourne, Vic, Australia

[4] DermEdge Res, Mississauga, ON, Canada

[5] Janssen Global Serv LLC, Raritan, NJ USA

[6] Janssen Res & Dev LLC, Raritan, NJ USA

[7] Univ Klinikum Hamburg Eppendorf, Hamburg, Germany

[8] Dermatol Res & Educ Fdn, Irvine, CA USA

[9] Univ Southern Calif, Los Angeles, CA 90007 USA

来源：

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2021年 / 85卷 / 03期

关键词：

D O I：

暂无

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

28096

引用

页码：AB174 / AB174

页数：1

共 50 条

[21] Sustained improvements in itch, skin pain, and health-related quality of life through 5 years of treatment with ixekizumab in patients with moderate to severe plaque psoriasis
Gooderham, Melinda
Elewski, Boni Elizabeth
Augustin, Matthias
Iversen, Lars
Torii, Hideshi
Burge, Russel
Zhu, Baojin
Gallo, Gaia
Eastman, William
Foley, Peter
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 83 (06) : AB19 - AB19
[22] SUSTAINED IMPROVEMENT IN HEALTH-RELATED QUALITY OF LIFE, WORK PRODUCTIVITY, EMPLOYABILITY AND REDUCED HEALTHCARE RESOURCE UTILIZATION OF PATIENTS WITH RHEUMATOID ARTHRITIS, PSORIATIC ARTHRITIS AND ANKYLOSING SPONDYLITIS TREATED WITH GOLIMUMAB: 5-YEAR RESULTS FROM THREE PHASE III STUDIES
Han, Chenglong
Kavanaugh, Arthur
Genovese, Mark C.
Deodhar, Atul
Hsu, Ben
Hsia, Elizabeth
RHEUMATOLOGY, 2014, 53 : 74 - 74
[23] Sustained Improvement In Health-Related Quality Of Life, Work Productivity, Employability, and Reduced Healthcare Resource Utilization Of Patients With Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis Treated With Golimumab: 5-Year Results From 3 Phase III Studies
Han, Chenglong
Kavanaugh, Arthur
Genovese, Mark C.
Hsu, Benjamin
Deodhar, Atul A.
Hsia, Elizabeth C.
ARTHRITIS AND RHEUMATISM, 2013, 65 : S137 - S137
[24] Relationship between clinical response to therapy and health-related quality of life outcomes in patients with moderate to severe plaque psoriasis
Revicki, Dennis A.
Willian, Mary K.
Menter, Alan
Saurat, Jean-Hilaire
Harnam, Neesha
Kaul, Martin
DERMATOLOGY, 2008, 216 (03) : 260 - 270
[25] Health-related quality of life outcomes in patients with moderate to severe psoriasis treated with ABT-874 versus etanercept or placebo
Menter, Alan
Signorovitch, James
Sundaram, Murali
Bao, Yanjun
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2011, 64 (02) : AB160 - AB160
[26] Malignancy rates through 5 years of follow-up in patients with moderate-to-severe psoriasis treated with guselkumab: Pooled results from the VOYAGE 1 and VOYAGE 2 trials
Blauvelt, Andrew
Lebwohl, Mark
Langley, Richard G.
Rowland, Katelyn
Yang, Ya-Wen
Chan, Daphne
Miller, Megan
You, Yin
Yu, Jenny
Thaci, Diamant
Foley, Peter
Papp, Kim A.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (02) : 274 - 282
[27] Real-world effectiveness of guselkumab in patients with psoriasis: Health-related quality of life and efficacy data from the noninterventional, prospective, German multicenter PERSIST trial
Gerdes, Sascha
Braeu, Beate
Hoffmann, Matthias
Korge, Bernhard
Mortazawi, Dariusch
Wiemers, Franca
Wegner, Sven
Personke, Yvonne
Gomez, Mario
Sticherling, Michael
JOURNAL OF DERMATOLOGY, 2021, 48 (12): : 1854 - 1862
[28] Malignancy rates through 5 years of follow-up in guselkumab-treated patients with moderate to severe psoriasis: Results from the VOYAGE 1 and 2 trials and comparisons to general populations
Blauvelt, Andrew
Langley, Richard G.
Ho, Vincent
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 87 (03) : AB79 - AB79
[29] Achieving and maintaining long-term optimal improvements in patient-reported symptoms, signs, and quality of life among patients with moderate to severe psoriasis treated with guselkumab: 3-year data from VOYAGE 1
Blauvelt, Andrew
Han, Chenglong
Papp, Kim A.
Griffiths, Christopher E. M.
Fernandez-Penas, Pablo
Adam, David N.
Philipp, Sandra
Song, Michael
Shen, Yaung-Kaung
Kimball, Alexa B.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 81 (04) : AB165 - AB165
[30] Achieving and maintaining long-term optimal improvements in patient-reported symptoms, signs, and quality of life among patients with moderate to severe psoriasis treated with guselkumab: 3-year data from VOYAGE 1
Blauvelt, A.
Han, C.
Papp, K. A.
Griffiths, C. E.
Fernandez-Penas, P.
Adam, D. N.
Philipp, S.
Song, M.
Shen, Y. -K.
Kimball, A. B.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2019, 33 : 49 - 49

← 1 2 3 4 5 →